ASSERTIO HOLDINGS INC (ASRT) Stock Price & Overview
NASDAQ:ASRT • US04546C3043
Current stock price
The current stock price of ASRT is 18.02 USD. Today ASRT is down by 0%. In the past month the price increased by 53.1%. In the past year, price increased by 96.81%.
ASRT Key Statistics
- Market Cap
- 116.229M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.21
- Dividend Yield
- N/A
ASRT Stock Performance
ASRT Stock Chart
ASRT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ASRT. When comparing the yearly performance of all stocks, ASRT is one of the better performing stocks in the market, outperforming 93.68% of all stocks.
ASRT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ASRT. ASRT has a bad profitability rating. Also its financial health evaluation is rather negative.
ASRT Earnings
On March 16, 2026 ASRT reported an EPS of -1.86 and a revenue of 13.54M. The company beat EPS expectations (32.71% surprise) and missed revenue expectations (-20.15% surprise).
ASRT Forecast & Estimates
10 analysts have analysed ASRT and the average price target is 39.02 USD. This implies a price increase of 116.51% is expected in the next year compared to the current price of 18.02.
For the next year, analysts expect an EPS growth of 64.49% and a revenue growth 4.25% for ASRT
ASRT Groups
Sector & Classification
ASRT Financial Highlights
Over the last trailing twelve months ASRT reported a non-GAAP Earnings per Share(EPS) of -3.21. The EPS increased by 6.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.38% | ||
| ROE | -32.33% | ||
| Debt/Equity | 0.42 |
ASRT Ownership
ASRT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.38 | 878.257B | ||
| JNJ | JOHNSON & JOHNSON | 20.6 | 573.153B | ||
| MRK | MERCK & CO. INC. | 23.56 | 297.058B | ||
| PFE | PFIZER INC | 9.07 | 155.52B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.17 | 118.543B | ||
| ZTS | ZOETIS INC | 17.12 | 50.689B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.45 | 27.937B | ||
| VTRS | VIATRIS INC | 5.58 | 16.104B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.91 | 11.863B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.122B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.497B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.072B | ||
| CORT | CORCEPT THERAPEUTICS INC | 80.5 | 4.606B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ASRT
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Company Info
IPO: 1997-02-12
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045 US
CEO: Daniel A. Peisert
Employees: 58
Phone: 12244197106
ASSERTIO HOLDINGS INC / ASRT FAQ
Can you describe the business of ASSERTIO HOLDINGS INC?
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
What is the stock price of ASSERTIO HOLDINGS INC today?
The current stock price of ASRT is 18.02 USD.
What is the dividend status of ASSERTIO HOLDINGS INC?
ASRT does not pay a dividend.
How is the ChartMill rating for ASSERTIO HOLDINGS INC?
ASRT has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for ASRT stock?
10 analysts have analysed ASRT and the average price target is 39.02 USD. This implies a price increase of 116.51% is expected in the next year compared to the current price of 18.02.
What is the market capitalization of ASRT stock?
ASSERTIO HOLDINGS INC (ASRT) has a market capitalization of 116.23M USD. This makes ASRT a Micro Cap stock.
What is the Short Interest ratio of ASSERTIO HOLDINGS INC (ASRT) stock?
The outstanding short interest for ASSERTIO HOLDINGS INC (ASRT) is 4.78% of its float.